Daily herpes medication can reduce HSV-2 transmission in a studied setting, but it does not eliminate risk. For a dating couple, the useful discussion has three parts: whether treatment fits the person taking it, which findings apply to their diagnosis and what precautions and boundaries both people want to agree on.
“I take medication” can be reassuring, but it often leaves the next question unanswered. Does that mean a daily prescription or tablets used during an outbreak? Is the goal fewer symptoms, reducing transmission or both? And does a partner hear “lower risk” as “no risk”?
Answering those questions gives you something more useful than a headline percentage: a plan both people understand.
Daily suppression and outbreak treatment are different plans
ASHA describes two approaches to recurrent herpes treatment. Episodic treatment is used at the start of an outbreak to help manage that episode. Suppressive treatment is taken daily to help keep outbreaks under control. A prescription used only during outbreaks is not the same schedule as daily suppression. ASHA’s treatment overview.
Before discussing what medication changes for your relationship, describe your actual plan. You do not need to tell a date the dose or share a prescription photo. “I take a daily antiviral prescribed by my clinician” or “I have medicine to use when an outbreak starts” is a clearer beginning than “I’m on treatment.”
If you are unsure what your prescription is intended to do, ask the prescriber or pharmacist. Do not change the schedule because a date is coming up or because a partner expects a particular routine.
What the transmission study actually found
A major 2004 trial followed 1,484 heterosexual, monogamous couples in which one partner had symptomatic genital HSV-2 and the other was susceptible. Couples were assigned daily valacyclovir or placebo for the partner with HSV-2. Both groups received safer-sex counseling and were offered condoms. Over eight months, HSV-2 was acquired by 14 of 743 susceptible partners in the treatment group and 27 of 741 in the placebo group. Corey and colleagues, New England Journal of Medicine.
| Daily valacyclovir group | Placebo group |
|---|---|
| 14 of 743 partners 1.9% | 27 of 741 partners 3.6% |
The reported proportions differ by 1.7 percentage points. You may also see the study described as roughly halving risk. Those are two ways of describing the comparison, not two different promises. Neither figure is the chance of transmission during one sexual encounter.
For a couple, the distinction matters because “half” can sound more certain than it is. The result supports a benefit in that study, alongside the counseling and prevention support participants received. It does not tell two people what will happen on their next date.
Does the finding fit your HSV diagnosis?
If you have symptomatic genital HSV-2
CDC guidance includes daily suppressive treatment as one option to discuss for reducing HSV-2 transmission in appropriate circumstances. It recommends combining the strategy with consistent condom use and avoiding sexual activity during recurrences. CDC treatment guidance. Ask your clinician how your history and treatment goals fit that advice.
If you have genital HSV-1
The same CDC guidance says suppression to prevent genital HSV-1 transmission has not been studied. That is a reason to ask about HSV-1 specifically rather than applying the HSV-2 study’s percentage to yourself.
If your diagnosis or test result is still unclear
Begin by clarifying the diagnosis. A treatment statistic cannot resolve uncertainty about which condition you have. Bring the original result and your questions to the clinician; do not start a relationship discussion from a diagnosis you have inferred from an online chart.
A shared plan needs more than a prescription
Say what happens if symptoms appear
Talk about this before a weekend away or an overnight visit. CDC advises avoiding vaginal, anal and oral sex during herpes symptoms and notes that condoms reduce risk without removing it completely. CDC prevention information.
The relationship question is how you will handle a change of plan. Can either person say “not tonight” without being challenged? Would you still want dinner or a movie, or would you prefer to reschedule? Agreeing on that in advance can prevent an uncomfortable moment from becoming a debate.
Keep the person taking medication in the decision
A partner’s concern deserves a hearing, but so do the practical realities of taking a prescription. At an appointment, explain your symptoms, questions about side effects, other medicines, costs and what you want treatment to achieve. Ask what to do if the plan is difficult to follow.
A useful request is, “Can we discuss what options fit me?” It leaves room for both symptom management and transmission concerns without treating medication as an admission fee for a relationship.
Allow each person time to decide
One person can feel ready after a conversation while the other wants clinical advice. Avoid setting a deadline based on the next date or a prepaid trip. You can continue social dates, agree to postpone sexual contact or decide that your preferences do not fit.
“I take a daily antiviral and have discussed it with my clinician. It can reduce risk in some HSV-2 situations, but it doesn’t remove it. I’d like us to talk about precautions and what we’re each comfortable with before we decide about sex.”
Bring these questions to the appointment
- My goal: Am I treating outbreaks, considering daily suppression, or discussing both?
- My diagnosis: Which transmission findings apply to my HSV type and symptom history?
- My routine: What should I know about other medicines, side effects, refills and missed doses?
- Our plan: What precautions should we discuss alongside treatment?
- Follow-up: When should I contact you if symptoms or circumstances change?
Write down the answer to the question you came in with. If your main concern was transmission, leave knowing what the clinician said about that goal, rather than assuming a prescription automatically answered it.
What both people should understand before intimacy
You should be able to describe the treatment plan honestly, explain that it does not make risk disappear and say what happens if either person wants to pause. Your partner should have room to ask questions and make their own choice, without being asked to treat a study result as a guarantee.
You do not need matching levels of medical knowledge. You need a shared understanding of what you have agreed to. If one person means “we have discussed medication” and the other means “we have agreed to sex without condoms,” the conversation is not finished.
Sources
- American Sexual Health Association: Treatment for Herpes, Understanding the Options.
- Corey et al., New England Journal of Medicine, 2004: Once-Daily Valacyclovir to Reduce the Risk of Transmission of Genital Herpes.
- CDC: Genital Herpes, STI Treatment Guidelines.
- CDC: About Genital Herpes.
Sources checked November 11, 2026. This article offers general information and conversation prompts, not a prescription or a personal risk calculation.